CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Vizionary Wealth Management has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Life Science Financial Services Companies - 2023,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Wayne Wagner Jr, President.

Vizionary Wealth Management
The Challenge of Personal Finance for Biotech Executives

Vizionary Wealth Management

Wayne Wagner Jr, Vizionary Wealth Management | Life Science Review | Top Life Science Financial Services CompaniesWayne Wagner Jr, president
The life sciences and pharmaceutical industries have seen drastic changes in regard to how the industry is structured, especially around R&D. One such shift is the offloading of research and development to specialty-purpose organizations to compartmentalize risks.

Consequently, it’s a do-or-die environment for smaller biotech companies. If they are successful, the financial upside is significant. If they strike out, it can be the end of the road for the organization.

The constant threat of high turnover mixed with complex personal compensation models often weighted toward Long Term Equity creates unique challenges.

Vizionary Wealth Management, a leading specialized wealth management firm with nearly two decades of experience, helps executives in the life science industry navigate this complexity.

Their experience provides them with a unique perspective, especially fit for executives in the pharma, life sciences, and biotech arena. With experience-earned knowledge of the industry, their team advises executives through critical questions like complex compensation models, tax implications, and benefit structures. Additionally, they assist their clients in negotiating aspects of offers for a job change, the next promotion, or managing your exit from the organization.

Their team works to help clients consider decisions that would position them to maximize opportunity and manage vocational risks. The end goal is a clear plan that aligns with their vision for the life, lifestyle, and legacy they want to achieve.

“Our personalized financial roadmap helps clients in the life science industry execute financial strategies that go beyond accumulating wealth to craft an intentional life, lifestyle, and legacy,” says Wayne Wagner Jr, president of Vizionary Wealth Management.

One of the distinctives of Vizionary Wealth Management is their emphasis on tax mitigation, a key topic for high-income executives who may struggle to grasp their tax liability in light of their complex and variable compensation packages.

Our personalized financial roadmap helps clients in the life science industry execute financial strategies to craft an intentional life, lifestyle, and legacy

“Stock market fluctuations are beyond our control. That is why we focus on managing their tax and investment costs, adding enormous value to their accumulated wealth over time,” shares Wagner.

Vizionary Wealth Management also has a unique business model, streamlining the cost structure of client investments and money management costs to reduce fees as clients grow their wealth.

It’s this commitment to client outcomes that drives their creativity to serve clients.

Wayne Wagner Jr. shared a recent example in which their team helped a life sciences executive. A recruiter was singularly focused on getting the client a ten percent increase in base salary, but missed the fact the client would give up seven percent of their bonus target and miss out on nine percent contributions to their retirement plan with their current employer. Following this, the firm communicated with the recruiter and hiring company to restructure a compensation plan to meet all the client’s objectives focusing on total compensation over time, not myopically focusing on just base compensation.

True to its name, Vizionary Wealth Management provides the Perspective for the Decisions Ahead.

Top 10 Life Science Financial Services Companies - 2023
Current Issue

Company : Vizionary Wealth Management

Management
Wayne Wagner Jr, president

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/vizionary-wealth-management